Camarda Financial Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Camarda Financial Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,648	Closed	-$925K	–	265
2014 Q4	$925K	Buy	5,648 +1,668	+42%	+$277K	0.59%	47
2014 Q3	$639K	Sell	3,980 -134	-3%	-$20.6K	0.44%	44
2014 Q2	$605K	Sell	4,114 -1,318	-24%	-$183K	0.41%	44
2014 Q1	$753K	Sell	5,432 -1,358	-20%	-$204K	0.58%	43
2013 Q4	$859K	Sell	6,790 -42	-0.6%	-$4.35K	0.7%	41
2013 Q3	$628K	Buy	6,832 +1,661	+32%	+$134K	0.82%	26
2013 Q2	$355K	Buy	+5,171	New	+$316K	0.32%	48

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Camarda Financial Advisors's JAZZ Position: Q1 2015 in Review

Camarda Financial Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 5,648 shares — an estimated $925K sold.

Camarda Financial Advisors first reported a position in JAZZ in Q2 2013 and held it in 7 quarters. The position peaked at $925K in Q4 2014. 354 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

Camarda Financial Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Camarda Financial Advisors sold 5,648 Jazz Pharmaceuticals shares in Q1 2015, an estimated $925K.
Camarda Financial Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Camarda Financial Advisors's Jazz Pharmaceuticals position peaked at $925K in Q4 2014.
354 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on Camarda Financial Advisors's 13F filing for Q1 2015, filed 15 Apr 2015.